Summary
Overview
Work History
Education
Skills
References
Publications
Languages
Certification
Timeline
Generic
Vishnu Suresh Babu

Vishnu Suresh Babu

Baltimore

Summary

Accomplished Molecular Biology Researcher specializing in organelle communication, autophagy, and metabolic changes linked to aging. Expertise in CRISPR technology and cell line engineering, driving innovative models that enhance understanding of stress signaling and cellular senescence. Strong project management skills foster collaboration and propel advancements in cancer and metabolic research.

Overview

15
15
years of professional experience
3
3
Certifications

Work History

Postdoctoral Fellow

The Johns Hopkins University
08.2024 - Current
  • Conducted research on organelle communication and signal transduction in aging models using iPSC and CRISPR technologies.
  • Developed models to elucidate TERT-driven signaling mechanisms in autophagy and ER stress.
  • Collaborated with interdisciplinary teams to advance project development and execution.
  • Analyzed data with statistical software to validate research findings.
  • Explored novel drug discovery and target mechanisms to enhance therapeutic strategies.
  • Focused on metabolic alterations in cellular processes related to aging.
  • Investigated advanced biomedical techniques and methodologies for improved understanding.

Research Fellow

University of California, San Francisco
08.2021 - 07.2024
  • Investigated tyrosine kinase signaling pathways in epithelial cancers to identify novel therapeutic targets aimed at reducing cancer recurrence.
  • Elucidated oncogenic tyrosine kinase circuits and addiction pathways using xenograft models and primary cultures to enhance understanding of therapeutic resistance.

Research Fellow

Grow Research Laboratory, Narayana Nethralaya Research Foundation
Bangalore Area
07.2014 - 06.2021
  • Identified key metabolic vulnerabilities in retinoblastoma, facilitating discovery of novel drug targets via multi-omic profiling and development of 3D tumor spheroid models.
  • Conducted literature reviews to support ongoing research projects.
  • Collaborated with faculty to design experimental protocols and methodologies.
  • Analyzed data using statistical software to identify trends and patterns.

Research Fellow

Indian Institute of Technology, Kanpur
03.2013 - 12.2013
  • Conducted research on transfection of bone marrow stromal cells with WNT proteins, contributing to advancements in cartilage repair techniques.
  • Conducted literature reviews to support innovative research projects at a leading medical institution.
  • Collaborated with multidisciplinary teams to design and execute experimental protocols effectively.
  • Analyzed data using statistical software to derive insights from complex research findings.

Project Trainee

Central Tuber Crops Research Institute (CTCRI)
Thiruvananthapuram Area
01.2011 - 05.2011
  • Standardized RNA extraction protocols and diagnosed viruses in sweet potato research to support disease management efforts.
  • Assisted in project planning and execution for agricultural research initiatives.
  • Coordinated data collection and analysis for tuber crop studies.
  • Collaborated with scientists to develop experimental protocols and procedures.

Education

Ph.D. - Oncology

University of Maastricht
Maastricht, Netherlands
05-2023

Master of Science - Stem cell and regenerative medicine

University of Sheffield
Sheffield, United Kingdom
02-2013

Bachelor of Engineering - Biotechnology

Vinayaka Missions University
Salem, Tamil Nadu, India
06-2011

Skills

  • Stem cell and iPSC technology
  • CRISPR applications
  • iPSC Flp-In and knockout methods
  • Human and cancer cell lines
  • 3D tumor modeling
  • Cancer pathway analysis
  • Drug discovery techniques
  • Omics analysis
  • Metabolic profiling
  • Research methodologies
  • Galaxy pipeline usage
  • Gene expression analysis
  • Data visualization skills
  • Statistical modeling expertise
  • Grant writing

References

References available upon request

Publications

  • A non-canonical AKT1-TERT pathway coordinates autophagy and ERphagy., Suresh Babu, V., Ghosh, S., Bammidi, S., Jiwon, R., Sharma, R., Meyer, D., Hose, S., Pattabiraman, P., Sahel, J., Kidley, N., Braz, N., Slater, M., Lang, S., Ghosh, A., Yi, J., Sripathi, S., Rangaramanujam, K., Bharti, K., & Sinha, D., Nature Communications, 2025, Manuscript under review, https://doi.org/10.1101/2025.11.24.690135
  • STING activation induces polarized cytokine secretion of IFN-β and IL-17A, promoting photoreceptor death and choroidal disruption in age-related macular degeneration., Huang, C., Suresh Babu, V., Bammidi, S., Arnold, J. N., Ebeling, M., Widmer, G., Strassburger, P., Lazendic, M., Grüner, S., Koester, J., Dutta, P., Hose, S., Singh, S., Gautam, P., Lad, E. M., Westenskow, P. D., Kutsyr, O., Csaky, K. G., Ghosh, S., Sripathi, S. R., Proia, A. D., Flores-Bellver, M., Sinha, D., & Feenstra, D., Cell death and disease, 2025, accepted in principle; joint first author
  • Age-Dependent Histone Deacetylase 3 Regulation by βA3/A1- Crystallin and Inositol Hexaphosphate in Retinal Pigmented Epithelial Cells Reveals a Novel Pathway in Age-Related Macular Degeneration., Chatterjee S, Ghosh S, Sin Z, Suresh Babu V, Preval LV, Davis E, Tran N, Bammidi S, Gautam P, Hose S, Sergeev Y, Flores-Bellver M, Ritter K, Jessen HJ, Al Diri I, Sinha D, Guha P., Aging Cell, 2025, 07/15/25, 40662679
  • MLST8 overexpression in RPE cells disrupts autophagy through novel mechanisms affecting AMD pathogenesis., Bammidi S, Ghosh S, Chowdhury O, Suresh Babu, V., Dutta P, Hose S, Sinha D., Autophagy, 2025, 04/14/25, 40205682
  • Activated mTOR Signaling in the RPE Drives EMT, Autophagy, and Metabolic Disruption, Resulting in AMD-Like Pathology in Mice., Chowdhury, O., Bammidi, S., Gautam, P., Suresh Babu, V., Liu, H., Shang, P., Xin, Y., Mahally, E., Nemani, M., Koontz, V., Lathrop, K., Kedziora, K. M., Franks, J., Sun, M., Smith, J. W., DeVine, L. R., Cole, R. N., Stepicheva, N., Strizhakova, A., Chattopadhyay, S., Sinha, D., Aging cell, 2025, 02/17/25, 39957408
  • Depleted hexokinase1 and lack of AMPKα activation favor OXPHOS-dependent energetics in retinoblastoma tumors., Suresh Babu V, Mallipatna A, Dudeja G, Shetty R, Nair AP, Tun SBB, Ho CEH, Chaurasia SS, Bhattacharya SS, Verma NK, Lakshminarayanan R, Guha N, Heymans S, Barathi VA, Ghosh A., Translational Research, 2023, 07/06/23, 37419277
  • Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a., Suresh Babu V, Bisht A, Mallipatna A, Sa D, Dudeja G, Kannan R, Shetty R, Guha N, Heymans S, Ghosh A., Cancers (Basel), 2022, 10/19/22, 36291907, PMC9600213
  • Lack of Retinoblastoma Protein Shifts Tumor Metabolism from Glycolysis to OXPHOS and Allows the Use of Alternate Fuels., Suresh Babu V, Dudeja G, Sa D, Bisht A, Shetty R, Heymans S, Guha N, Ghosh., Cells, 2022, 10/11/22, 36291051, PMC9600484
  • Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors., Suresh Babu V, Mallipatna A, Sa D, Dudeja G, Kannan R, Shetty R, Nair AP, Gundimeda S, Chaurasia SS, Verma NK, Lakshminarayanan R, Heymans S, Barathi VA, Guha N, Ghosh A., Cells, 2022, 05/18/22, 35626705, PMC9139581
  • Selective Induction of Intrinsic Apoptosis in Retinoblastoma Cells by Novel Cationic Antimicrobial Dodecapeptides., Suresh Babu V, Kizhakeyil A, Dudeja G, Chaurasia SS, Barathi VA, Heymans S, Verma NK, Lakshminarayanan R, Ghosh A., Pharmaceutics, 2022, 11/18/22, 36432697, PMC9694048
  • Retinoblastoma genetics screening and clinical management., Gupta H, Malaichamy S, Mallipatna A, Murugan S, Jeyabalan N, Suresh Babu V, Ghosh A, Ghosh A, Santhosh S, Seshagiri S, Ramprasad VL, Kumaramanickavel G., BMC Med Genomics, 2021, 07/22/21, 34294096, PMC8296631
  • Type 1-type 2 interferon imbalance in dry eye disease., Panigrahi T, D'Souza S, Suresh Babu V, Dickman MM, Nuijts RMMA, Sethu S, Shetty R., Indian J Ophthalmol, 2023, 04/01/23, 37026295, PMC10276729
  • Host factors related to SARS-CoV2 infection in the human eye and prophylaxis thereof., S. D’Souza, Suresh Babu V, T. Panigrahi, R. Shetty, P. Khamar, P. B, Sethu S, Ghosh., 2022, in press
  • Integrated Transcriptomics and Metabolomics Study of Retinoblastoma Using Agilent Microarrays and LC / MS / GC / MS Platforms Application Note., N. Guha, S. Gundimeda, A. Padmanaban, A. Mallipatna, Suresh Babu V, Ghosh A., 2015, Agilent Technologies

Languages

English
Full Professional
Malayalam
Full Professional
Tamil
Professional
Hindi
Professional

Certification

Human Subject Research - Biomedical Research CITI program

Timeline

Postdoctoral Fellow

The Johns Hopkins University
08.2024 - Current

Research Fellow

University of California, San Francisco
08.2021 - 07.2024

Research Fellow

Grow Research Laboratory, Narayana Nethralaya Research Foundation
07.2014 - 06.2021

Research Fellow

Indian Institute of Technology, Kanpur
03.2013 - 12.2013

Project Trainee

Central Tuber Crops Research Institute (CTCRI)
01.2011 - 05.2011

Ph.D. - Oncology

University of Maastricht

Master of Science - Stem cell and regenerative medicine

University of Sheffield

Bachelor of Engineering - Biotechnology

Vinayaka Missions University
Vishnu Suresh Babu